Where Science Meets Real-World Applications

ATTD-ASIA is a groundbreaking expansion of ATTD – the leading international meeting point where clinicians, diabetes care providers, researchers, industries, investors, reimbursement authorities, and people with diabetes assemble with the aim of sharing knowledge and developing collaborations.

We’re working to provide a Scientific Program filled with the latest therapies for diabetes management!

You are invited to explore the initial Scientific Program structure
Interactive Program*
Day by Day Schedule*

 * Subject to changes. Correct as of 23 March 2026

Initial Titles & Speakers

Opening Lecture: Toward the Development of Personalized Diabetes Care

Kohjiro Ueki, Japan

Clinical Utility and Interpretation of CGM in Prediabetes

Jee Hee Yoo, Korea

AI and Hypoglycemia Prediction

Pratik Choudhary, UK

CGM and AID in Chronic Kidney Disease

Elaine Chow, Hong Kong

Using GLP-1 Analogues to Prevent Gestational Diabetes

Judie Dodd, Australia

Consensus in Incretin Use
in T1D

Satish Garg, USA

Diabetes in Asians: Implications for Subtyping; CGM Accuracy Gaps and Implications

Daphne Gardner, Singapore

East Meets West – Advancing
Diabetes Technology
Across Asia

Amit Gupta, India

Evaluation Of CGM-Based Insulin Dose Guidance System In People With T1D And T2D: Single-Arm Feasibility Study

Andrej Janež, Slovenia

Youth-Onset T2D in Asia:
Bridging Guidelines and Real-World Practice

Muhammad Yazid Jalaludin, Malaysia

National Big Data-Based Insights Into Pediatric Diabetes Epidemiology and Complications

Jae Hyun Kim, Korea

CGM and Smart Pens in People
Living With T2D Using Insulin


Jae Hyeon Kim, Korea

Integration of Diabetes Technology (CGM and Insulin Pump) in Pediatric Care: Real-World Evidence and Clinical Outcomes

Jae Hyun Kim, Korea

Precision Diagnostics and
Therapeutics in Young-Onset Diabetes in Asia

Ronald CW Ma, Singapore

CGM Metrics for Predicting GDM
in Asians

Queenie Ling Jun Li, Singapore

Monogenic Diabetes and Its Prevalence in Asia

Viswanathan Mohan, India

Lifestyle Medicine – “The Basis” for Modern Care

Emina Obarcanin, Singapore

Medical Insights From CGM Beyond Glucose Control

Sarah Price, Australia

Novel Avenues for Potential Future Therapies Aimed at Improving Metabolic Control in Diabetes (Gene Therapies, Endoluminal Resurfacing)

David O’Neal, Australia

Integrating CGM and Automation
of Insulin Delivery Into Hospital Care




David O’Neal, Australia

What Can a CGM Signal Tell Us About
Insulin Resistance in Non-Diabetic
Adults?

Smadar Shilo, Israel

Sex Differences in Continuous Glucose Monitoring Profiles: Insights From a Non-Diabetic Population

Smadar Shilo, Israel

Evidence of Using AID in T2D and How AID Could Reduce Therapeutic Inertia

Viral Shah, USA

Using GLP-1 RA With Exercise
in T1D

Stephen Twigg, Australia

How Can We Screen Children for T2D?

Tatsuhiko Urakami, Japan

Clinical Implications of TIR, CV, and GRI

Jee Hee Yoo, Korea

Continuous Glucose Monitoring in Gestational Diabetes 

Sun-Joon Moon, Korea